What is W Keith Thornton DDS?
Operating at the intersection of dental innovation and sleep medicine, W Keith Thornton DDS, through its Airway Management division, provides sophisticated therapeutic solutions for sleep-disordered breathing. The company is best known for its pioneering work in oral appliance therapy, specifically the Nylon flexTAP, which represents a significant advancement in digitally printed, single-point midline devices. By addressing the clinical needs of patients suffering from obstructive sleep apnea and chronic snoring, the firm has established a robust B2B2C model that bridges the gap between dental practitioners and sleep physicians. Their commitment to precision-engineered, patient-centric care positions them as a critical player in the non-invasive sleep disorder treatment market, effectively challenging traditional CPAP-centric paradigms.
How much funding has W Keith Thornton DDS raised?
W Keith Thornton DDS has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in W Keith Thornton DDS
PPP
Public-Private Partnership
What's next for W Keith Thornton DDS?
The infusion of capital from this late-stage financing round is expected to catalyze the company's expansion into broader international markets and accelerate the research and development of next-generation digital sleep appliances. As the firm transitions into this growth phase, strategic priorities will likely include the optimization of its digital manufacturing supply chain and the expansion of its clinical education programs for healthcare providers. By leveraging this recent investment, W Keith Thornton DDS is well-positioned to capture additional market share, further cementing its reputation as a leader in the evolving landscape of sleep health technology and personalized medical devices.
See full W Keith Thornton DDS company page
